Published in Cancer Weekly, October 25th, 1999
T. Nishimura and colleagues from the Hokkaido University, Japan, investigated the role of T helper type 1 (Th1) and Th2 cells in tumor immunity using Th cells induced from ovalbumin (OVA)-specific T-cell receptor transgenic mice. Their results were reported in the Journal of Experimental Medicine ("Distinct Role of Antigen-Specific T Helper Type 1 (Th1) and Th2 Cells in Tumor Eradication in vivo," Journal of Experimental Medicine, September 6, 1999;190(5):617-627).
"Although Th1 cells exhibited stronger cytotoxicity than Th2 cells, both cell types completely...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.